News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
201,098 Results
Type
Article (20998)
Company Profile (23)
Press Release (180077)
Section
Business (50624)
Career Advice (328)
Deals (7215)
Drug Delivery (39)
Drug Development (25873)
Employer Resources (31)
FDA (5454)
Job Trends (4400)
News (89776)
Policy (8380)
Tag
2024 BioCapital Digital (1)
2024 BioForest Digital (2)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (2)
2024 Biotech Beach Digital (1)
2024 Biotech Beach Standard (1)
2024 Genetown Standard (1)
2024 Pharm Country Digital (1)
2024 Pharm Country Standard (1)
2026 Genetown Elite (1)
Academia (1877)
Adcomms (13)
Allergies (20)
Alliances (15538)
ALS (26)
Alzheimer's disease (552)
Antibody-drug conjugate (ADC) (28)
Approvals (5458)
Artificial intelligence (94)
Autoimmune disease (2)
Automation (3)
Bankruptcy (59)
Best Places to Work (3768)
BIOSECURE Act (17)
Biosimilars (14)
Biotechnology (13)
Bladder cancer (20)
Brain cancer (10)
Breast cancer (84)
Cancer (663)
Cardiovascular disease (132)
Career advice (298)
Career pathing (9)
CAR-T (48)
Cell therapy (137)
Cervical cancer (9)
Clinical research (20434)
Collaboration (243)
Compensation (24)
Complete response letters (4)
COVID-19 (1205)
CRISPR (15)
C-suite (69)
Cystic fibrosis (23)
Data (639)
Decentralized trials (1)
Denatured (40)
Depression (7)
Diabetes (68)
Diagnostics (2012)
Digital health (3)
Diversity (8)
Diversity, equity & inclusion (9)
Drug discovery (32)
Drug pricing (40)
Drug shortages (5)
Duchenne muscular dystrophy (39)
Earnings (13252)
Editorial (8)
Employer branding (3)
Employer resources (27)
Events (25352)
Executive appointments (175)
FDA (5803)
Featured Employer (5)
Friedreich's ataxia (3)
Frontotemporal dementia (3)
Funding (300)
Gene editing (33)
Generative AI (3)
Gene therapy (120)
GLP-1 (231)
Government (1526)
Grass and pollen (1)
Guidances (12)
Healthcare (6236)
Huntington's disease (2)
IgA nephropathy (4)
Immunology and inflammation (16)
Indications (6)
Infectious disease (1246)
Inflammatory bowel disease (37)
Inflation Reduction Act (6)
Influenza (9)
Intellectual property (22)
Interviews (36)
IPO (3370)
IRA (25)
Job creations (791)
Job search strategy (273)
Kidney cancer (5)
Labor market (9)
Layoffs (82)
Leadership (3)
Legal (1553)
Liver cancer (21)
Lung cancer (104)
Lymphoma (46)
Machine learning (1)
Management (11)
Manufacturing (70)
MASH (12)
Medical device (4049)
Medtech (4049)
Mergers & acquisitions (3978)
Metabolic disorders (184)
Multiple sclerosis (17)
NASH (5)
Neurodegenerative disease (20)
Neuropsychiatric disorders (4)
Neuroscience (680)
NextGen: Class of 2025 (2079)
Non-profit (2389)
Northern California (574)
Now hiring (5)
Obesity (97)
Opinion (62)
Ovarian cancer (31)
Pain (24)
Pancreatic cancer (15)
Parkinson's disease (27)
Partnered (8)
Patents (48)
Patient recruitment (31)
Peanut (9)
People (18074)
Pharmaceutical (9)
Pharmacy benefit managers (2)
Phase I (6140)
Phase II (8837)
Phase III (6872)
Pipeline (251)
Podcasts (112)
Policy (66)
Postmarket research (1211)
Preclinical (2813)
Press Release (19)
Prostate cancer (32)
Psychedelics (14)
Radiopharmaceuticals (60)
Rare diseases (106)
Real estate (1605)
Recruiting (13)
Regulatory (5894)
Reports (11)
Research institute (1943)
Resumes & cover letters (26)
Rett syndrome (1)
RNA editing (1)
RSV (10)
Schizophrenia (19)
Series A (48)
Series B (19)
Sickle cell disease (21)
Southern California (518)
Special edition (1)
Spinal muscular atrophy (39)
Sponsored (4)
Startups (1325)
Stomach cancer (3)
Supply chain (16)
The Weekly (69)
United States (5840)
Vaccines (253)
Venture capitalists (11)
Webinars (3)
Weight loss (70)
Women's health (15)
Worklife (6)
Date
Today (11)
Last 7 days (175)
Last 30 days (775)
Last 365 days (9557)
2025 (2132)
2024 (10010)
2023 (11634)
2022 (15224)
2021 (16674)
2020 (15886)
2019 (14532)
2018 (10899)
2017 (9678)
2016 (9900)
2015 (11635)
2014 (8686)
2013 (7374)
2012 (7688)
2011 (8028)
2010 (7501)
Location
Africa (237)
Alabama (29)
Alaska (3)
Arizona (76)
Arkansas (6)
Asia (11407)
Australia (2532)
California (1348)
Canada (603)
China (95)
Colorado (71)
Connecticut (54)
Delaware (47)
Europe (26042)
Florida (251)
Georgia (32)
Idaho (12)
Illinois (159)
India (5)
Indiana (71)
Japan (46)
Kansas (24)
Kentucky (11)
Louisiana (1)
Maine (9)
Maryland (202)
Massachusetts (1043)
Michigan (33)
Minnesota (113)
Missouri (33)
Montana (6)
Nebraska (6)
Nevada (16)
New Hampshire (15)
New Jersey (575)
New Mexico (10)
New York (481)
North Carolina (293)
North Dakota (3)
Northern California (574)
Ohio (66)
Oklahoma (8)
Oregon (10)
Pennsylvania (302)
Puerto Rico (3)
Rhode Island (9)
South America (334)
South Carolina (8)
Southern California (518)
Tennessee (42)
Texas (267)
Utah (37)
Virginia (28)
Washington D.C. (33)
Washington State (162)
West Virginia (1)
Wisconsin (11)
201,098 Results for "montreal heart institute".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Shining a spotlight on the Montreal Chest Institute
February 28, 2025
·
5 min read
FDA
The Montreal Heart Institute Welcomes FDA Approval of Colchicine for the Treatment of Cardiovascular Diseases
The Montreal Heart Institute (MHI) welcomes the approval by the United States Food and Drug Administration (FDA) of colchicine for cardiovascular prevention.
June 23, 2023
·
2 min read
Press Releases
Cardiol Therapeutics Announces Publication of Research in the Journal of the American College of Cardiology: Basic to Translational Science That Supports Development of Its Proprietary Subcutaneous Drug Candidate, CRD-38, for the Treatment of Heart Failure
Data demonstrates improvement in cardiac function and reductions in cardiac hypertrophy, remodeling, inflammation, and cell death - key underlying mechanisms in heart failure
February 20, 2025
·
7 min read
Press Releases
Protembis Announces Formation of New Scientific Advisory Board Comprised of World-Renowned Structural Heart Experts
March 18, 2025
·
4 min read
Press Releases
NYU Langone Heart Cardiologists Present at ACC’s 75th Annual Scientific Session
March 28, 2025
·
6 min read
Press Releases
Chronic Heart Failure Market Size to Reach USD 20.3 Billion by 2035, Impelled by Escalating Prevalence of Coronary Artery and Heart Valve Diseases
January 29, 2025
·
11 min read
Approvals
Roche Continues Regulatory Run With Acute Stroke Expansion for Heart Attack Drug
TNKase is the first stroke drug to win FDA approval in nearly three decades.
March 4, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Caristo Secures FDA Clearance, Ushering in a New Era of AI-Powered Heart Attack Prevention
March 11, 2025
·
4 min read
Press Releases
Abbott Receives CE Mark for its Volt™ Pulsed Field Ablation System to Treat Patients with Abnormal Heart Rhythms
March 28, 2025
·
6 min read
Press Releases
Initiation of ReDS-SAFE HF II Trial for Advancing Heart Failure Management
February 24, 2025
·
3 min read
1 of 20,110
Next
